Public Profile

CSL Behring (Australia) Pty Ltd

CSL Behring (Australia) Pty Ltd, a subsidiary of CSL Limited, is a leading global biotechnology company headquartered in Australia. Established in 1904, CSL Behring has evolved into a key player in the biopharmaceutical industry, focusing on the development and manufacture of innovative therapies for people with serious and rare diseases. With major operational regions across Australia, Europe, and North America, CSL Behring is renowned for its core products, including immunoglobulins, clotting factors, and albumin. These therapies are distinguished by their high quality and efficacy, addressing critical health needs in areas such as immunology and haematology. As a pioneer in the field, CSL Behring has achieved significant milestones, including the introduction of groundbreaking treatments that have transformed patient care. The company’s commitment to research and development solidifies its position as a trusted leader in the biopharmaceutical market.

DitchCarbon Score

How does CSL Behring (Australia) Pty Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

18

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

CSL Behring (Australia) Pty Ltd's score of 18 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

CSL Behring (Australia) Pty Ltd's reported carbon emissions

CSL Behring (Australia) Pty Ltd currently does not have publicly available carbon emissions data for the most recent year, nor are there specific reduction targets or climate pledges outlined in their initiatives. As a leading biopharmaceutical company, CSL Behring is expected to engage in sustainable practices and contribute to climate action, but without specific figures or commitments, it is challenging to assess their current impact on carbon emissions. The company operates within an industry that increasingly prioritises environmental responsibility, and it is anticipated that they will align with broader climate goals in the future.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. CSL Behring (Australia) Pty Ltd's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for CSL Behring (Australia) Pty Ltd is in AU, which has a very high grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

CSL Behring (Australia) Pty Ltd is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Hualan Bio

CN
Chemicals nec
Updated 3 days ago

Grifols

ES
Medical, precision and optical instruments, watches and clocks (33)
Updated 1 day ago

Baxter

US
Health and social work services (85)
Updated 2 days ago

Sinco Pharma

CN
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers